.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Argus Health
QuintilesIMS
Cantor Fitzgerald
Fish and Richardson
Harvard Business School
McKinsey
Citi
Johnson and Johnson
Healthtrust

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018612

« Back to Dashboard

NDA 018612 describes NICORETTE (MINT), which is a drug marketed by Glaxosmithkline and is included in two NDAs. It is available from four suppliers. Additional details are available on the NICORETTE (MINT) profile page.

The generic ingredient in NICORETTE (MINT) is nicotine polacrilex. There are twenty-nine drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the nicotine polacrilex profile page.

Summary for 018612

Tradename:2
Applicant:1
Ingredient:1
Patents:1
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 018612

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NICORETTE nicotine polacrilex GUM, CHEWING;BUCCAL 018612 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0135-0157 0135-0157-11 1 BLISTER PACK in 1 CARTON (0135-0157-11) > 200 GUM, CHEWING in 1 BLISTER PACK
NICORETTE nicotine polacrilex GUM, CHEWING;BUCCAL 018612 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0135-0157 0135-0157-12 1 BLISTER PACK in 1 CARTON (0135-0157-12) > 220 GUM, CHEWING in 1 BLISTER PACK

Summary for product number 002

Active Rx/OTC/Discontinued:OTCDosage:GUM, CHEWING;BUCCALStrengthEQ 2MG BASE
Approval Date:Feb 9, 1996TE:RLD:Yes
Patent:► SubscribePatent Expiration:Apr 30, 2028Product Flag?Substance Flag?Delist Request?

Summary for product number 003

Active Rx/OTC/Discontinued:OTCDosage:GUM, CHEWING;BUCCALStrengthEQ 2MG BASE
Approval Date:Dec 23, 1998TE:RLD:Yes

Summary for product number 004

Active Rx/OTC/Discontinued:OTCDosage:GUM, CHEWING;BUCCALStrengthEQ 2MG BASE
Approval Date:Sep 25, 2000TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Merck
Farmers Insurance
Baxter
Chubb
Cipla
Boehringer Ingelheim
Federal Trade Commission
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot